Literature DB >> 480047

Aspirin dosage for infants and children.

A K Done, S J Yaffe, J M Clayton.   

Abstract

The labeled dosage schedule that has long been on pediatric aspirin preparations is at variance with the recommendation in authoritative medical references, studies demonstrating antipyretic effectiveness in children, and the prescribing habits of pediatricians as revealed by a poll conducted by the authors. Aspirin pharmacokinetics are influenced by a number of physiologic factors, as well as by dosage, and complicate the problem of assuring safe and effective pediatric use. Basic pharmacokinetic considerations indicate that the increase in size of individual doses needed to assure therapeutic salicyate blood levels, thereby removing the temptation of parents to administer the drug too often, is made permissible (i.e., safe while effective) by expanding the interdose interval to four hours instead of three. A revised pediatric aspirin disage schedule is presented that better meets the practices of the pediatric community and the needs of consumers.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 480047     DOI: 10.1016/s0022-3476(79)80783-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Correlation between dosage and antipyretic effect of aspirin in children.

Authors:  A Vigano; A Dalla Villa; I Cecchini; G C Biasini; N Principi
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Platelet Inhibition in Shunted Infants on Aspirin at Short and Midterm Follow-Up.

Authors:  Dongngan T Truong; Joyce T Johnson; David K Bailly; Jason R Clawson; Xiaoming Sheng; Phillip T Burch; Madolin K Witte; L LuAnn Minich
Journal:  Pediatr Cardiol       Date:  2016-12-30       Impact factor: 1.655

Review 4.  Treatment of fever in childhood.

Authors:  D Adam; G Stankov
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

5.  Anti-platelet agents in pediatric cardiac practice.

Authors:  Sweta Mohanty; Balu Vaidyanathan
Journal:  Ann Pediatr Cardiol       Date:  2013-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.